Publications Autoimmune Channelopathy Group

J. Li, A. Maguy.
Autoimmune channelopathies: questions remain. Nat. Rev. Cardiol. 14(9):566, 2017 DOI

M. Lettino, P. Andell, U. Zeymer, P. Widimsky, N. Danchin, A. Bardaji, J.A. Barrabes, A. Cequier, M.J. Claeys, L. De Luca, J. Dörler, D. Erlinge, P. Erne, P. Goldstein, S.M. Koul, G. Lemesle, T.F. Lüscher, C.M. Matter, G. Montalescot, D. Radovanovic, J.L. Sendón, P. Tousek, F. Weidinger, C.F. Weston, A. Zaman, J. Li, J.W. Jukema.
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes. Eur Heart J Cardiovasc Pharmacotherapy 3(4):198-213, 2017 DOI

U. Zeymer, P. Widimsky, N. Danchin, M. Lettino, A. Bardaji, J.A. Barrabes, A. Cequier, M.J. Claeys, L. De Luca, J. Dörler, D. Erlinge, P. Erne, P. Goldstein, S.M. Koul, G. Lemesle, T.F. Lüscher, C.M. Matter, G. Montalescot, D. Radovanovic, J.L. Sendón, P. Tousek, F. Weidinger, C.F.M. Weston, A. Zaman, P. Andell, J. Li, J.W. Jukema.
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries. Eur Heart J Cardiovasc Pharmacotherapy 2 (4): 229-243, 2016 DOI

N. Danchin, M. Lettino, U. Zeymer, P. Widimsky, A. Bardaji, J.A. Barrabes, A. Cequier, M.J. Claeys, L. De Luca, J. Dörler, D. Erlinge, P. Erne, P. Goldstein, S.M. Koul, G. Lemsle, T.F. Lüscher, C.M. Matter, G. Montalescot, R. Dragana, J.L. Sendón, P. Tousek, F. Weidinger, C.F.M. Weston, A. Zaman, P. Andell, J. Li, W. Jumeka.
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries. Eur Heart J Cardiovasc Pharmacotherapy 2 (3): 152-167, 2016 DOI

J. Li, J. Franke, R. Pribe-Wolferts, B. Meder, P. Ehlermann, D. Mereles, F. Andre, M.A. Abdelrazek, C. Merten, P.A. Schweizer, R. Becker, H.A. Katus, D. Thomas.
Effects of β-blocker therapy on electrocardiographic and echocardiographic characteristics of left ventricular noncompaction. Clin Res Cardiol 104:241-9, 2015 DOI

J. Li, A. Maguy, J.E. Duverger, P. Vigneault, P. Comtois, Y. Shi, J.C. Tardif, D. Thomas, S. Nattel.
Induced KCNQ1 autoimmunity accelerates cardiac repolarization in rabbits: potential significance in arrhythmogenesis and antiarrhythmic therapy. Heart Rhythm 11:2092-100, 2014 DOI

C. Seyler, J. Li, P.A. Schweizer, H.A. Katus, D. Thomas.
Inhibition of cardiac two-pore-domain K+ (K 2P) channels by the novel antiarrhythmic drug vernakalant – Comparison with flecainide. Eur J Pharmacol 724:51-7, 2014 DOI

J. Li, C. Seyler, F. Wiedmann, C. Schmidt, P.A. Schweizer, R. Becker, H.A. Katus, D. Thomas.
Anti-KCNQ1 K+ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathy. Cardiovasc. Res. 98:496-503, 2013 DOI

J. Li, S. Goeser, F. Leuschner, H.C. Volz, S. Buss, M. Andrassy, R. Oettl, G. Pfitzer, H.A. Katus, Z. Kaya.
Mucosal tolerance induction in autoimmune myocarditis and myocardial infarction. Int J Cardiol 162:245-52, 2013 DOI

S. Korkmaz, E. Zitron, A. Bangert, C. Seyler, S. Li, P. Hegedues, D. Scherer, J. Li, T. Fink, P.A. Schweizer, E. Giannitsis, M. Karck, G. Szabó, H.A. Katus, Z. Kaya.
Provocation of an autoimmune response to cardiac voltage-gated sodium channel Nav1.5 induces cardiac conduction defects in rats. J Am Coll Cardiol 62:340-9, 2013 DOI

J. Li, R. Becker, B. Rauch, R. Schiele, S. Schneider, T. Riemer, F. Diller, H. Gohlke, M. Gottwik, G. Steinbeck, G. Sabin, H.A. Katus, J. Senges.
Usefulness of heart rate to predict one-year mortality in patients with atrial fibrillation and acute myocardial infarction (from the OMEGA trial). Am J Cardiol 111:811-5, 2013 DOI

J. Li, A. Warth, P. Schnabel, P.A. Schweizer, S. Buss, H. Steen, R. Becker, H.A. Katus, D. Thomas.
Electrophysiological findings in Fabry cardiomyopathy: mapping the maze of risk stratification. Acta Cardiol 76:481-5, 2012 DOI

H.C. Volz, S. Buss, J. Li, S. Goeser, M. Andrassy, R. Oettl, G. Pfitzer, H.A. Katus, Z. Kaya.
Autoimmunity against cardiac troponin I in ischaemia reperfusion injury. Eur J Heart Fail 10:1052-9, 2011 DOI

J. Li, E. Zitron, H.A. Katus, R. Becker.
PMS – Premenstrual storm? An unusual cause of electrical storm in a young woman with vasospastic angina. Clin Res Cardiol 4:367-71, 2011 DOI

J. Li, E. Zitron, H.A. Katus, R. Becker.
Seventh try’s a charm – Ventricular fibrillation terminated by the seventh shock. Circ. Arrhythm. Electrophysiol. 4:e4-6, 2011 DOI

J. Li, F. Leuschner, S. Goeser, L. Reinhardt, R. Oettl, P. Bride, G. Pfitzer, A. Remppis, E. Giannitsis, H.A. KatusA, Z. Kaya.
Absence of autoantibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Eur Heart J 29:1949-55, 2008 DOI

Z. Kaya, S. Goeser, S. Buss, F. Leuschner, M. Völkers, R. Oettl, J. Li, S. Zittrich, G. Pfitzer, N.R. Rose, H.A. Katus.
Identification of cardiac troponin I sequence motifs leading to heart failure by inducing myocardial inflammation and fibrosis. Circulation 118:2063-72, 2008 DOI